🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for High-risk Pregnancy

Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) NCT06075264Phase 25 sites📍 Fort Myers📍 Indianapolis📍 Cleveland Frantz Viral Therapeutics, LLC · Tests: Artesunate ointment, Placebo ointment A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies NCT07195916Phase 122 sites📍 Duarte📍 La Jolla📍 Ann Arbor Incyte Corporation · Tests: INCA036873 A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations NCT05503797Phase 270 sites📍 Beverly Hills📍 San Francisco📍 Westwood, Los Angeles Fore Biotherapeutics · Tests: Plixorafenib 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT Immediate Chemotherapy Following Resection for High-Risk Non-Muscle-Invasive Bladder Cancer NCT06889623NA1 site📍 Shanghai Changhai Hospital · Tests: Immediate postoperative chemotherapy A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) NCT07222488Phase 1, Phase 217 sites📍 Bakersfield📍 New Brunswick📍 Myrtle Beach Merck Sharp & Dohme LLC · Tests: MK-3120 Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT). NCT07022470Phase 21 site📍 Palo Alto Stanford University · Tests: 3-Fraction HDR Brachytherapy, 4-Fraction HDR Brachytherapy A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing NCT07036731NA1 site📍 Nanjing The First Affiliated Hospital with Nanjing Medical Universi… · Tests: Urine biomarker -Guided without reTURBT A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer NCT07532434n/a1 site📍 Beijing Peking University Third Hospital Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC) NCT05931393Phase 21 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Cabozantinib 80 MG High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors NCT06418789Phase 21 site📍 Saint Petersburg N.N. Petrov National Medical Research Center of Oncology · Tests: High-dose chemotherapy (TI- 2 cycles, CE- 3 cycles ) Kidney Cancer DNA Registry NCT02087852n/a7 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: salvia for germline DNA, the Kidney Cancer Questionnaire, Family History Questionnaire (when applicable), Blood draw, E… Follow-up Visit of High Risk Infants NCT00009633n/a31 sites📍 Birmingham📍 Los Angeles📍 Palo Alto NICHD Neonatal Research Network · Tests: No Intervention High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins NCT06835426NA1 site📍 Ghent Algemeen Ziekenhuis Maria Middelares · Tests: Single intravenous injection of the radiotracer, Imaging resected specimen using the high-resolution PET-CT specimen im… Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer NCT06441110Phase 31 site📍 Fuzhou Fujian Medical University Union Hospital · Tests: Tislelizumab in Combination with Bacillus Calmette-Guérin Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer NCT06976892Phase 13 sites📍 Cambridge📍 Sutton📍 Cardiff Institute of Cancer Research, United Kingdom · Tests: Dose Level 2 (starting dose), Dose Level 1, Dose Level -1, Dose Level 3, Maximum Tolerated Dose Pregnancy Salt Substitution Trial for Hypertensive Disorders of Pregnancy Prevention (PREG-Salt) NCT07294807NA110 sites📍 Bishan📍 Fuling📍 Gunan Peking University · Tests: Potassium-enriched salt substitute, Usual salt Mother-infant Bonding in the Brain: a Mindfulness-based Intervention NCT05830266NA1 site📍 Tilburg Tilburg University · Tests: "Mindful with your Baby" group-based therapist-guided intervention, "Mindful with your baby" self-g… DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition NCT05770102Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Atezolizumab A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy NCT06362369Phase 1, Phase 25 sites📍 Aurora📍 Lake Mary📍 Lebanon 7 Hills Pharma, LLC · Tests: Alintegimod, Ipilimumab, Nivolumab Collection and Distribution of Biospecimens for Novel Research Uses NCT03848962n/a2 sites📍 Huntsville📍 Lexington iSpecimen Inc Commercial or Open Source Closed Loop Impact on Pregnancy Study NCT06654713n/a1 site📍 San Francisco University of California, San Francisco · Tests: Commercial AID system, Open source AID system Prehabilitation in High-risk Oncologic Surgery NCT07638410NA1 site📍 Philadelphia Fox Chase Cancer Center · Tests: Multidisciplinary Prehabilitation Program Safety, Tolerability, and Preliminary Efficacy of BH011 in Subjects With Non-Muscle-Invasive Bladder Cancer NCT06732531Phase 1, Phase 26 sites📍 Beijing📍 Xiamen📍 Changsha Zhuhai Beihai Biotech Co., Ltd · Tests: BH011 FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support for Kids NCT07718464n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Furosemide Stress Test Clinical Decision Support Tool Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI NCT04954599Phase 1, Phase 25 sites📍 Brussels📍 Ghent📍 Maastricht Maastricht University Medical Center · Tests: CP-506, Carboplatin, Immune checkpoint inhibitor Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy NCT07000084Phase 360 sites📍 Birmingham📍 Fairbanks📍 Gilbert Alliance for Clinical Trials in Oncology · Tests: BCG Solution, Biopsy of Bladder, Cystoscopy, Computed Tomography, Magnetic Resonance Imaging Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine NCT07275333NA1 site📍 Zaporizhzhya Karolinska Institutet · Tests: HPV Self-Sampling Kit Early Detection of Gestational Diabetes Mellitus in Pregnancy NCT05388643NA1 site📍 Worcester University of Massachusetts, Worcester · Tests: Enhanced First Trimester GDM Screening, Routine Gestational Diabetes Screening Effect of High Versus Standard Protein Intake in Critically Ill Patients With Acute Kidney Injury Requiring Continuous Renal Replacement Therapy NCT07596043NA1 site📍 Bangkok Chulalongkorn University · Tests: High protein group, Standard protein group
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy